Citations for
1FPLD2, ITM2A
Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation
Davies SJ, Ryan J, O'Connor PBF, Kenny E, Morris D, Baranov PV, O'Connor R, McCarthy TV.
Adipocyte 7 Oct 2;6(4):259-276. doi: 10.1080/21623945.2017.1362510. Epub 2017 Sep 5 2017
2FPLD2, LMNA
Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
Subramanyam L, Simha V, Garg A.
Clin Genet 78(1):66-73. Epub 2009 Dec 22. 2010
3FPLD2, LMNA
A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D, Lado-Abeal J, Palos-Paz F, Lattanzi G, Bandín MA, Bellido D, Domínguez-Gerpe L, Calvo C, Pérez O, Ramazanova A, Martínez-Sánchez N, Victoria B, Costa-Freitas AT.
Clin Endocrinol (Oxf) 69(1):61-8. Epub 2008 Jul 1.PMID: 18031308 2008
4LMNA, FPLD2
Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
Lanktree M, Cao H, Rabkin S, Hanna A, Hegele R.
Clin Genet 71(2):183-6. No abstract available. 2007
5LMNA, FPLD2
New Metabolic Phenotypes in Laminopathies: LMNA Mutations in Patients with Severe Metabolic Syndrome.
Decaudain A, Vantyghem MC, Guerci B, HŽcart AC, Auclair M, Reznik Y, Narbonne H, Ducluzeau PH, Donadille B, LebbŽ C, BŽrŽziat V, Capeau J, Lascols O, Vigouroux C.
J Clin Endocrinol Metab 92(12):4835-44. Epub 2007 Aug 21. 2007
6LMNA, FPLD2
The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy.
Muschke P, Kšlsch U, Jakubiczka S, Wieland I, Brune T, Wieacker P.
Am J Med Genet A 143(23):2810-4. 2007
7LMNA, FPLD2
Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy.
Boguslavsky RL, Stewart CL, Worman HJ.
Hum Mol Genet 15(4):653-63. Epub 2006 Jan 13. 2006
8LMNA, EMD2 , LGMD1B , CMD1A , CMT2B1 , FPLD2 , MADYS1 , PRO1 , WRN2 , RDMP2 , LDHCP , EMD3 , MCPRS
The laminopathies: a clinical review.
Rankin J, Ellard S.
Clin Genet 70(4):261-74. 2006
9LMNA, EMD2, EMD3, LGMD1B, CMD1A, CMT2B1, FPLD2, MADYS1, PRO1, WRN2, RDMP2 , LDHCP, MCPRS
Human laminopathies: nuclei gone genetically awry.
Capell BC, Collins FS.
Nat Rev Genet 7(12):940-52. 2006
10LMNA, PRO1, EMD2, CMD1A, FPLD2
LMNA mutation position predicts organ system involvement in laminopathies.
Hegele R.
Clin Genet 68(1):31-4. 2005
11LMNA , FPLD2, EMD2
Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells.
Bechert K, Lagos-Quintana M, Harborth J, Weber K, Osborn M.
Exp Cell Res 286(1):75-86. 2003
12FPLD2, LMNA
Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy.
Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H.
Arterioscler Thromb Vasc Biol 23(1):111-6. 2003
13FPLD2, LMNA, SREBF1
A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.
Lloyd DJ, Trembath RC, Shackleton S.
Hum Mol Genet 11(7):769-77. 2002
14FPLD2, LMNA, MXD1
Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C.
Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D'Apice MR, Massart C, Capon F, Sbraccia P, Federici M, Lauro R, Tudisco C, Pallotta R, Scarano G, Dallapiccola B, Merlini L, Bonne G.
Am J Hum Genet 71(2):426-31. 2002
15FPLD2, LMNA
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.
Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC.
Nat Genet 24(2):153-6. 2000
16FPLD2, LMNA
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM.
Am J Hum Genet 66(4):1192-8. 2000
17FPLD2, LMNA
Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.
Cao H, Hegele RA.
Hum Mol Genet 9(1):109-12. 2000
18CMD1A, EMD2, FPLD2, LGMD1B, LMNA
Mutations in the LMNA gene encoding lamin A/C.
Genschel J, Schmidt HH.
Hum Mutat 16(6):451-9. 2000
19FPLD2
Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22.
Anderson JL, et al.
Am J Med Genet 82 : 161-165. 1999
20FPLD2
Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22.
Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A.
Nat Genet 18(3):292-5. 1998
21FPLD2
A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q.
Jackson SN, Pinkney J, Bargiotta A, Veal CD, Howlett TA, McNally PG, Corral R, Johnson A, Trembath RC.
Am J Hum Genet 63 : 534-540. 1998